Novonesis Statistics
Total Valuation
Novonesis has a market cap or net worth of 29.30 billion. The enterprise value is 31.02 billion.
| Market Cap | 29.30B |
| Enterprise Value | 31.02B |
Important Dates
The next estimated earnings date is Thursday, May 8, 2025.
| Earnings Date | May 8, 2025 |
| Ex-Dividend Date | Apr 4, 2025 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 346.70M |
Valuation Ratios
The trailing PE ratio is 92.54.
| PE Ratio | 92.54 |
| Forward PE | n/a |
| PS Ratio | 7.38 |
| PB Ratio | 2.53 |
| P/TBV Ratio | 24.57 |
| P/FCF Ratio | 41.52 |
| P/OCF Ratio | 27.75 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 25.32, with an EV/FCF ratio of 43.96.
| EV / Earnings | 97.98 |
| EV / Sales | 7.13 |
| EV / EBITDA | 25.32 |
| EV / EBIT | 32.54 |
| EV / FCF | 43.96 |
Financial Position
The company has a current ratio of 1.73, with a Debt / Equity ratio of 0.16.
| Current Ratio | 1.73 |
| Quick Ratio | 1.05 |
| Debt / Equity | 0.16 |
| Debt / EBITDA | 1.66 |
| Debt / FCF | 2.64 |
| Interest Coverage | 10.48 |
Financial Efficiency
Return on equity (ROE) is 4.67% and return on invested capital (ROIC) is 6.61%.
| Return on Equity (ROE) | 4.67% |
| Return on Assets (ROA) | 5.54% |
| Return on Invested Capital (ROIC) | 6.61% |
| Return on Capital Employed (ROCE) | 5.97% |
| Revenue Per Employee | 375,056 |
| Profits Per Employee | 29,918 |
| Employee Count | 10,582 |
| Asset Turnover | 0.40 |
| Inventory Turnover | 3.05 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +17.31% in the last 52 weeks. The beta is 0.56, so Novonesis's price volatility has been lower than the market average.
| Beta (5Y) | 0.56 |
| 52-Week Price Change | +17.31% |
| 50-Day Moving Average | 58.61 |
| 200-Day Moving Average | 60.89 |
| Relative Strength Index (RSI) | 57.89 |
| Average Volume (20 Days) | 2,935 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Novonesis had revenue of 3.97 billion and earned 316.60 million in profits. Earnings per share was 1.14.
| Revenue | 3.97B |
| Gross Profit | 2.06B |
| Operating Income | 872.66M |
| Pretax Income | 431.83M |
| Net Income | 316.60M |
| EBITDA | 1.12B |
| EBIT | 872.66M |
| Earnings Per Share (EPS) | 1.14 |
Balance Sheet
The company has 289.89 million in cash and 1.86 billion in debt, giving a net cash position of -1.57 billion.
| Cash & Cash Equivalents | 289.89M |
| Total Debt | 1.86B |
| Net Cash | -1.57B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 11.57B |
| Book Value Per Share | 41.64 |
| Working Capital | 819.03M |
Cash Flow
In the last 12 months, operating cash flow was 1.06 billion and capital expenditures -350.24 million, giving a free cash flow of 705.66 million.
| Operating Cash Flow | 1.06B |
| Capital Expenditures | -350.24M |
| Free Cash Flow | 705.66M |
| FCF Per Share | n/a |
Margins
Gross margin is 52.00%, with operating and profit margins of 21.99% and 7.98%.
| Gross Margin | 52.00% |
| Operating Margin | 21.99% |
| Pretax Margin | 10.88% |
| Profit Margin | 7.98% |
| EBITDA Margin | 28.23% |
| EBIT Margin | 21.99% |
| FCF Margin | 17.78% |
Dividends & Yields
This stock pays an annual dividend of 0.92, which amounts to a dividend yield of 1.49%.
| Dividend Per Share | 0.92 |
| Dividend Yield | 1.49% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 81.65% |
| Buyback Yield | -0.64% |
| Shareholder Yield | 0.85% |
| Earnings Yield | 1.08% |
| FCF Yield | 2.41% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Novonesis has an Altman Z-Score of 5.27.
| Altman Z-Score | 5.27 |
| Piotroski F-Score | n/a |